GENB Earnings Generate Biomedicines, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–2 of 2
| Q1 2026 | 2026-03-31 | -1.07 | 2026-05-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.62 | 2026-05-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.